Ether-à-go-go 1 (Eag1) Potassium Channel Expression in Dopaminergic Neurons of Basal Ganglia is Modulated by 6-hydroxydopamine Lesion

Overview

Journal Neurotox Res

Publisher Springer

Specialty Neurology

Date 2011 Nov 4

PMID 22048886

Citations 8

Authors

N R Ferreira

M Mitkovski

W Stuhmer

L A Pardo

E A Del Bel

Affiliations

Soon will be listed here.

Abstract

The ether à go-go (Eag) gene encodes the voltage-gated potassium (K(+)) ion channel Kv10.1, whose function still remains unknown. As dopamine may directly affect K(+) channels, we evaluated whether a nigrostriatal dopaminergic lesion induced by the neurotoxin 6-hydroxydopamine (6-OHDA) would alter Eag1-K(+) channel expression in the rat basal ganglia and related brain regions. Male Wistar rats received a microinjection of either saline or 6-OHDA (unilaterally) into the medial forebrain bundle. The extent of the dopaminergic lesion induced by 6-OHDA was evaluated by apomorphine-induced rotational behavior and by tyrosine hydroxylase (TH) immunoreactivity. The 6-OHDA microinjection caused a partial or complete lesion of dopaminergic cells, as well as a reduction of Eag1+ cells in a manner proportional to the extent of the lesion. In addition, we observed a decrease in TH immunoreactivity in the ipsilateral striatum. In conclusion, the expression of the Eag1-K(+)-channel throughout the nigrostriatal pathway in the rat brain, its co-localization with dopaminergic cells and its reduction mirroring the extent of the lesion highlight a physiological circuitry where the functional role of this channel can be investigated. The Eag1-K(+) channel expression in dopaminergic cells suggests that these channels are part of the diversified group of ion channels that generate and maintain the electrophysiological activity pattern of dopaminergic midbrain neurons.

Citing Articles

Intellectual Disability and Potassium Channelopathies: A Systematic Review.

Kessi M, Chen B, Peng J, Tang Y, Olatoutou E, He F Front Genet. 2020; 11:614.

PMID: 32655623 PMC: 7324798. DOI: 10.3389/fgene.2020.00614.

The environmental toxicant ziram enhances neurotransmitter release and increases neuronal excitability via the EAG family of potassium channels.

Harrigan J, Brambila D, Meera P, Krantz D, Schweizer F Neurobiol Dis. 2020; 143:104977.

PMID: 32553709 PMC: 8501297. DOI: 10.1016/j.nbd.2020.104977.

Eag1 K Channel: Endogenous Regulation and Functions in Nervous System.

Han B, Tokay T, Zhang G, Sun P, Hou S Oxid Med Cell Longev. 2017; 2017:7371010.

PMID: 28367272 PMC: 5358448. DOI: 10.1155/2017/7371010.

The involvement of Eag1 potassium channels and miR-34a in rotenone-induced death of dopaminergic SH-SY5Y cells.

Horst C, Titze-de-Almeida R, Titze-de-Almeida S Mol Med Rep. 2017; 15(4):1479-1488.

PMID: 28259991 PMC: 5364983. DOI: 10.3892/mmr.2017.6191.

Neurotoxin mechanisms and processes relevant to Parkinson's disease: an update.

Segura-Aguilar J, Kostrzewa R Neurotox Res. 2015; 27(3):328-54.

PMID: 25631236 DOI: 10.1007/s12640-015-9519-y.

References

Liss B, Roeper J . ATP-sensitive potassium channels in dopaminergic neurons: transducers of mitochondrial dysfunction. News Physiol Sci. 2001; 16:214-7. DOI: 10.1152/physiologyonline.2001.16.5.214. View

Redman P, Jefferson B, Ziegler C, Mortensen O, Torres G, Levitan E . A vital role for voltage-dependent potassium channels in dopamine transporter-mediated 6-hydroxydopamine neurotoxicity. Neuroscience. 2006; 143(1):1-6. PMC: 2673085. DOI: 10.1016/j.neuroscience.2006.08.039. View

Martin S, Lino de Oliveira C, Mello de Queiroz F, Pardo L, Stuhmer W, Del Bel E . Eag1 potassium channel immunohistochemistry in the CNS of adult rat and selected regions of human brain. Neuroscience. 2008; 155(3):833-44. DOI: 10.1016/j.neuroscience.2008.05.019. View

Morris L, Veeriah S, Chan T . Genetic determinants at the interface of cancer and neurodegenerative disease. Oncogene. 2010; 29(24):3453-64. PMC: 3005561. DOI: 10.1038/onc.2010.127. View

Congar P, Bergevin A, Trudeau L . D2 receptors inhibit the secretory process downstream from calcium influx in dopaminergic neurons: implication of K+ channels. J Neurophysiol. 2002; 87(2):1046-56. DOI: 10.1152/jn.00459.2001. View

Liss B, Roeper J . Individual dopamine midbrain neurons: functional diversity and flexibility in health and disease. Brain Res Rev. 2007; 58(2):314-21. DOI: 10.1016/j.brainresrev.2007.10.004. View

Ji H, Hougaard C, Frisch Herrik K, Strobaek D, Christophersen P, Shepard P . Tuning the excitability of midbrain dopamine neurons by modulating the Ca2+ sensitivity of SK channels. Eur J Neurosci. 2009; 29(9):1883-95. PMC: 4430859. DOI: 10.1111/j.1460-9568.2009.06735.x. View

Lujan R, de Cabo de la Vega C, Dominguez Del Toro E, Ballesta J, Criado M, Juiz J . Immunohistochemical localization of the voltage-gated potassium channel subunit Kv1.4 in the central nervous system of the adult rat. J Chem Neuroanat. 2003; 26(3):209-24. DOI: 10.1016/j.jchemneu.2003.07.006. View

Hegle A, Marble D, Wilson G . A voltage-driven switch for ion-independent signaling by ether-à-go-go K+ channels. Proc Natl Acad Sci U S A. 2006; 103(8):2886-91. PMC: 1413768. DOI: 10.1073/pnas.0505909103. View

10.

Bajaj A, Driver J, Schernhammer E . Parkinson's disease and cancer risk: a systematic review and meta-analysis. Cancer Causes Control. 2010; 21(5):697-707. DOI: 10.1007/s10552-009-9497-6. View

11.

Browne D, Gancher S, Nutt J, Brunt E, Smith E, Kramer P . Episodic ataxia/myokymia syndrome is associated with point mutations in the human potassium channel gene, KCNA1. Nat Genet. 1994; 8(2):136-40. DOI: 10.1038/ng1094-136. View

12.

Liss B, Haeckel O, Wildmann J, Miki T, Seino S, Roeper J . K-ATP channels promote the differential degeneration of dopaminergic midbrain neurons. Nat Neurosci. 2005; 8(12):1742-51. DOI: 10.1038/nn1570. View

13.

Pardo L, del Camino D, Sanchez A, Alves F, Bruggemann A, Beckh S . Oncogenic potential of EAG K(+) channels. EMBO J. 1999; 18(20):5540-7. PMC: 1171622. DOI: 10.1093/emboj/18.20.5540. View

14.

Shieh C, Coghlan M, Sullivan J, Gopalakrishnan M . Potassium channels: molecular defects, diseases, and therapeutic opportunities. Pharmacol Rev. 2000; 52(4):557-94. View

15.

Barneoud P, Parmentier S, Mazadier M, Miquet J, Boireau A, Dubedat P . Effects of complete and partial lesions of the dopaminergic mesotelencephalic system on skilled forelimb use in the rat. Neuroscience. 1995; 67(4):837-48. DOI: 10.1016/0306-4522(95)00112-v. View

16.

Pearson G, Robinson F, Beers Gibson T, Xu B, Karandikar M, Berman K . Mitogen-activated protein (MAP) kinase pathways: regulation and physiological functions. Endocr Rev. 2001; 22(2):153-83. DOI: 10.1210/edrv.22.2.0428. View

17.

Salthun-Lassalle B, Hirsch E, Wolfart J, Ruberg M, Michel P . Rescue of mesencephalic dopaminergic neurons in culture by low-level stimulation of voltage-gated sodium channels. J Neurosci. 2004; 24(26):5922-30. PMC: 6729237. DOI: 10.1523/JNEUROSCI.5668-03.2004. View

18.

Ju M, Wray D . Molecular identification and characterisation of the human eag2 potassium channel. FEBS Lett. 2002; 524(1-3):204-10. DOI: 10.1016/s0014-5793(02)03055-7. View

19.

Gao X, Ning Y . Cancer and Parkinson's disease: the odd couple. Drugs Today (Barc). 2011; 47(3):215-22. DOI: 10.1358/dot.2011.47.3.1519657. View

20.

Nair-Roberts R, Chatelain-Badie S, Benson E, White-Cooper H, Bolam J, Ungless M . Stereological estimates of dopaminergic, GABAergic and glutamatergic neurons in the ventral tegmental area, substantia nigra and retrorubral field in the rat. Neuroscience. 2008; 152(4):1024-31. PMC: 2575227. DOI: 10.1016/j.neuroscience.2008.01.046. View